Clinical trials sponsored by Peking Union Medical College Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Peking Union Medical College Hospital

• 177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer
  NCT05603559 · Phase: Early Phase 1 · Ages: 18 Years to 90 Years · Sex: Male · 1 location
• 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients
  NCT05324332 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: Male · 1 location
• 68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
  NCT05549024 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A National Registry on Chinese Patients With Lymphangioleiomyomatosis
  NCT03193892 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 1 location
• AI in Predicting Polyp Pathology and Endoscopic Classification
  NCT06773832 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study
  NCT07640048 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC
  NCT07452003 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
  NCT07062523 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer
  NCT06411678 · Phase: Early Phase 1 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
  NCT07464132 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Atrial Fibrillation Patients Treated With Catheter Ablation
  NCT05266144 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Belimumab After Rituximab in Resistant Primary Juvenile SS
  NCT06410833 · Phase: Phase 4 · Ages: 5 Years to 18 Years · Sex: All (male and female) · 1 location
• COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
  NCT06168032 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)
  NCT07719140 · Phase: Phase 4 · Ages: 6 Years to 18 Years · Sex: All (male and female) · 8 locations
• Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer
  NCT05871762 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Development and Validation of Microbiota and Metabolite-based Prediction Model for Recurrence of High-risk Colorectal Polyps After Polypectomy
  NCT06957626 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer
  NCT05424692 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Trastuzumab Biosimilars and Pertuzumab Biosimilars Combined With Chemotherapy for Neoadjuvant Treatment of Patients With Locally Advanced HER2-positive Rectal Cancer
  NCT07108127 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical Mutations
  NCT06674343 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Gut and Vaginal Microbiota Profile Study for HIV Women
  NCT05996016 · Phase: Not specified · Ages: 14 Years and older · Sex: Female · 1 location
• Observation of Exhaled VOC Biomarkers Characteristics in Admitted Women with Breast Ultrasound BI-RADS 4 Grade
  NCT06489158 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: Female · 1 location
• Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
  NCT06417502 · Phase: Not specified · Ages: Up to 18 Years · Sex: All (male and female) · 9 locations
• Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer
  NCT05804916 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• PUMCH Dementia Longitudinal Cohort Study
  NCT05023564 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Perioperative Statins to Prevent AFib After Lung Surgery
  NCT07727681 · Phase: Phase 4 · Ages: 60 Years and older · Sex: All (male and female) · 2 locations
• Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer
  NCT05751018 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Photoacoustic/Ultrasound Imaging for Breast Nodule Diagnosis, Molecular Classification, and Neoadjuvant Chemotherapy Response Evaluation
  NCT06908291 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Reasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer （NORESTO Study）
  NCT06194708 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Risk Factor Assessment for Acute Pulmonary Hypertension Crisis
  NCT07653958 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 4 locations
• Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases
  NCT05476627 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
  NCT05330923 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia
  NCT07670286 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
  NCT05866029 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 90 Years · Sex: All (male and female) · 58 locations
• The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer
  NCT03747588 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC)
  NCT06861543 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer
  NCT05802394 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer
  NCT05802407 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome
  NCT06545721 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Peking Union Medical College Hospital recruiting for?

Peking Union Medical College Hospital is the lead sponsor of 38 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.